Home > Cashflow Statement > NATCO PHARMA

NATCO PHARMA
Cash Flow from Investing Activities

    Back to Cashflow Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Investing Activities ₹-1,415 Cr₹-1,033 Cr₹-477 Cr₹-5.30 Cr₹-103 Cr

What is the latest Cash Flow from Investing Activities ratio of NATCO PHARMA ?

The latest Cash Flow from Investing Activities ratio of NATCO PHARMA is ₹-1,415 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Investing Activities
Mar2025₹-1,415 Cr
Mar2024₹-1,033 Cr
Mar2023₹-477 Cr
Mar2022₹-5.30 Cr
Mar2021₹-103 Cr

How is Cash Flow from Investing Activities of NATCO PHARMA Trending?

Years Cash Flow from Investing Activities % Change
Mar2025 ₹-1,415 Cr
Negative
Mar2024 ₹-1,033 Cr
Negative
Mar2023 ₹-477 Cr
Negative
Mar2022 ₹-5.30 Cr
Negative
Mar2021 ₹-103 Cr -

Compare Cash Flow from Investing Activities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,929.8 Cr 3% -5.7% -40.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,140.0 Cr 2.1% 2.4% -11.5% Stock Analytics
DIVIS LABORATORIES ₹175,290.0 Cr 0.7% 8.2% 8.1% Stock Analytics
CIPLA ₹132,417.0 Cr 5.6% 3.9% 1% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,839.0 Cr 1.5% 0.1% 1.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,031.0 Cr 3.7% -3% -6.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

3%

-5.7%

-40.9%

SENSEX

2.5%

2%

3.1%


You may also like the below Video Courses